Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Placebo
GLWL-01
Locations
1
United States
National Institute on Drug Abuse
Baltimore, Maryland, United States
Start Date
June 22, 2021
Primary Completion Date
December 4, 2023
Completion Date
December 4, 2023
Last Updated
January 15, 2025
NCT05855668
NCT07071779
NCT07413458
NCT06939088
NCT06793488
NCT06648642
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions